Format

Send to

Choose Destination
Nutr Rev. 2019 Dec 16. pii: nuz091. doi: 10.1093/nutrit/nuz091. [Epub ahead of print]

Dietary saturated fat and heart disease: a narrative review.

Author information

1
J.L. Heileson is with the Department of Health, Human Performance, and Recreation, Robbins College of Health and Human Sciences, Baylor University, Waco, Texas, USA.

Abstract

The American Heart Association (AHA) recently published a meta-analysis that confirmed their 60-year-old recommendation to limit saturated fat (SFA, saturated fatty acid) and replace it with polyunsaturated fat to reduce the risk of heart disease based on the strength of 4 Core Trials. To assess the evidence for this recommendation, meta-analyses on the effect of SFA consumption on heart disease outcomes were reviewed. Nineteen meta-analyses addressing this topic were identified: 9 observational studies and 10 randomized controlled trials. Meta-analyses of observational studies found no association between SFA intake and heart disease, while meta-analyses of randomized controlled trials were inconsistent but tended to show a lack of an association. The inconsistency seems to have been mediated by the differing clinical trials included. For example, the AHA meta-analysis only included 4 trials (the Core Trials), and those trials contained design and methodological flaws and did not meet all the predefined inclusion criteria. The AHA stance regarding the strength of the evidence for the recommendation to limit SFAs for heart disease prevention may be overstated and in need of reevaluation.

KEYWORDS:

heart disease; low-density lipoprotein cholesterol; meta-analysis; polyunsaturated fat; saturated fat; trans fat

PMID:
31841151
DOI:
10.1093/nutrit/nuz091

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center